Gw Henssler & Associates 13F: Cuts Lazard (LAZ) Stake by $10M

On October 26, 2026, Gw Henssler & Associates reduced its stake in Lazard, Inc. (LAZ) by 288,891 shares, leaving it with a total of 8,241 shares valued at approximately $298,569. This information comes from the fund's latest Form 13F filing with the SEC, which covered the quarter ending September 30, 2026.

Gw Henssler & Associates' cut represents a 97.2% decrease in their position. The fund's reported value for its entire portfolio is about $758.9 million, with Lazard making up 0.04% of that total.

LAZ Lazard, Inc.

$37.70 ▼ -21.80% year to date

1M 3M YTD

Daily close · Oct 26, 2026

Where Lazard Fits in Gw Henssler's Portfolio

Lazard ranks 39th out of 224 positions in Gw Henssler's portfolio. The significant cut indicates a shift in their investment strategy, even though the fund still holds a small position in Lazard.

Lazard, Inc. Stock Up 1.1%

Lazard shares recently traded around $37.70, which is below both the 50-day moving average of $39.28 and the 200-day moving average of $44.56. The stock is also 12.3% below the mean price target of $43.00 set by analysts, suggesting some analysts see potential for growth.

Recent Earnings

Lazard reported trailing twelve-month revenue of approximately $3.28 billion, with an EPS of $1.65. The next earnings report is scheduled for January 28, 2027.

Dividend

Lazard has a dividend rate of $2.00 per share, which translates to a yield of 5.37%. The high payout ratio of 98% indicates that the company is returning most of its earnings to shareholders.

Insider Buying and Selling at Lazard, Inc.

Several insiders have sold shares of Lazard in recent months. CEO Peter Richard Orszag sold 125,000 shares at an average price of $43.52 on August 25, 2026, totaling approximately $5.44 million. He also sold 69,170 shares earlier in the year. This trend of insider selling could signal a variety of strategic reasons.

Analysts Set New Price Targets

On October 1, 2026, Goldman Sachs maintained a 'Sell' rating with a target price of $36.00, while UBS maintained a 'Neutral' rating with a target of $40.00 on October 7, 2026. The consensus among analysts is to hold, with a mean target price of $43.00 based on eight opinions.

About Lazard

Lazard, Inc. operates as a financial advisory and asset management firm, offering services across various sectors and regions. The firm plays a significant role in capital markets, providing advisory services and managing assets for clients worldwide.

Bottom Line

Investors should watch for Lazard's upcoming earnings report on January 28, 2027, and be aware of any further filings from Gw Henssler & Associates regarding their position in the company. The significant cut in shares highlights a potential shift in strategy that could impact future performance.